Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Longitudinal Analysis of Human Memory T-Cell Response According to the Severity of Illness up to 8 Months After Severe Acute Respiratory Syndrome Coronavirus 2 Infection
Chang Kyung Kang, Minji Kim, Soojin Lee, et al.
The Journal of Infectious Diseases (2021) Vol. 224, Iss. 1, pp. 39-48
Open Access | Times Cited: 50

Showing 1-25 of 50 citing articles:

SARS-CoV-2 variants of concern partially escape humoral but not T cell responses in COVID-19 convalescent donors and vaccine recipients
Daryl Geers, Marc C. Shamier, Susanne Bogers, et al.
Science Immunology (2021) Vol. 6, Iss. 59
Open Access | Times Cited: 522
BNT162b2 vaccination induces durable SARS-CoV-2–specific T cells with a stem cell memory phenotype
Gisella Guerrera, Mario Picozza, Silvia D’Orso, et al.
Science Immunology (2021) Vol. 6, Iss. 66
Open Access | Times Cited: 205
Reduced Magnitude and Durability of Humoral Immune Responses to COVID-19 mRNA Vaccines Among Older Adults
Mark A. Brockman, Francis Mwimanzi, Hope R. Lapointe, et al.
The Journal of Infectious Diseases (2021) Vol. 225, Iss. 7, pp. 1129-1140
Open Access | Times Cited: 92
Naturally Acquired SARS-CoV-2 Immunity Persists for Up to 11 Months Following Infection
Valeria De Giorgi, Kamille A. West, Amanda N. Henning, et al.
The Journal of Infectious Diseases (2021) Vol. 224, Iss. 8, pp. 1294-1304
Open Access | Times Cited: 58
Elucidating reasons of COVID-19 re-infection and its management strategies
Vijay Kumar Jain, Karthikeyan P. Iyengar, Rakesh Garg, et al.
Diabetes & Metabolic Syndrome Clinical Research & Reviews (2021) Vol. 15, Iss. 3, pp. 1001-1006
Open Access | Times Cited: 48
A quest for universal anti-SARS-CoV-2 T cell assay: systematic review, meta-analysis, and experimental validation
Akshay Binayke, Aymaan Zaheer, Siddhesh Vishwakarma, et al.
npj Vaccines (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 7
Durability of SARS-CoV-2–Specific T-Cell Responses at 12 Months Postinfection
Zhongyan Lu, Eric D. Laing, Jarina Pena DaMata, et al.
The Journal of Infectious Diseases (2021) Vol. 224, Iss. 12, pp. 2010-2019
Open Access | Times Cited: 35
COVID-19 reinfection: the role of natural immunity, vaccines, and variants
Bao Y. Sciscent, Caroline Eisele, Lisa Ho, et al.
Journal of Community Hospital Internal Medicine Perspectives (2021) Vol. 11, Iss. 6, pp. 733-739
Open Access | Times Cited: 33
Durability of Functional SARS‐CoV‐2‐Specific Immunological Memory and T Cell Response up to 8–9 Months Postrecovery From COVID‐19
Diptee Trimbake, Dharmendra Pratap Singh, Y. K., et al.
Journal of Immunology Research (2025) Vol. 2025, Iss. 1
Open Access
Protection afforded by post-infection SARS-CoV-2 vaccine doses: A cohort study in Shanghai
Bo Zheng, Bronner P. Gonçalves, Pengfei Deng, et al.
eLife (2025) Vol. 13
Open Access
New infections by SARS-CoV-2 variants of concern after natural infections and post-vaccination in Rio de Janeiro, Brazil
Lívia R. Góes, Juliana D. Siqueira, Marianne M. Garrido, et al.
Infection Genetics and Evolution (2021) Vol. 94, pp. 104998-104998
Open Access | Times Cited: 24
Humoral and Cellular Immunogenicity of Six Different Vaccines against SARS-CoV-2 in Adults: A Comparative Study in Tunisia (North Africa)
Mélika Ben Ahmed, Hèdia Bellali, Mariem Gdoura, et al.
Vaccines (2022) Vol. 10, Iss. 8, pp. 1189-1189
Open Access | Times Cited: 17
Robust and Functional Immune Memory Up to 9 Months After SARS-CoV-2 Infection: A Southeast Asian Longitudinal Cohort
Hoa Thi My Vo, Alvino Maestri, Heidi Auerswald, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 15
Persistence of T Cell and Antibody Responses to SARS-CoV-2 Up to 9 Months after Symptom Onset
Jaclyn C. Law, Mélanie Girard, Gary Chao, et al.
The Journal of Immunology (2021) Vol. 208, Iss. 2, pp. 429-443
Open Access | Times Cited: 18
Broad humoral and cellular immunity elicited by one-dose mRNA vaccination 18 months after SARS-CoV-2 infection
Chang Kyung Kang, Hyun Mu Shin, Pyoeng Gyun Choe, et al.
BMC Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 13
Role of different types of RNA molecules in the severity prediction of SARS-CoV-2 patients
Pratheeba Jeyananthan
Pathology - Research and Practice (2023) Vol. 242, pp. 154311-154311
Open Access | Times Cited: 7
Children and Adults in a Household Cohort Study Have Robust Longitudinal Immune Responses Following SARS-CoV-2 Infection or Exposure
Melanie R. Neeland, Samantha Bannister, Vanessa Clifford, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 17
Distinct Immune Response at 1 Year Post-COVID-19 According to Disease Severity
Chang Kyung Kang, Minji Kim, Jisu Hong, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 12
Clonal diversity predicts persistence of SARS-CoV-2 epitope-specific T-cell response
Ksenia V. Zornikova, Alexandra Khmelevskaya, Savely A. Sheetikov, et al.
Communications Biology (2022) Vol. 5, Iss. 1
Open Access | Times Cited: 12
Treatment mechanism of immune triad from the repurposing drug against COVID-19
Jong‐Hoon Lee
Translational Medicine of Aging (2023) Vol. 7, pp. 33-45
Open Access | Times Cited: 6
Rapid Cytokine Release Assays for Analysis of Severe Acute Respiratory Syndrome Coronavirus 2–Specific T Cells in Whole Blood
Andreas Törnell, Hanna Grauers Wiktorin, Johan Ringlander, et al.
The Journal of Infectious Diseases (2022) Vol. 226, Iss. 2, pp. 208-216
Open Access | Times Cited: 10
Anti‐SARS‐CoV‐2 IgG antibody levels among Thai healthcare providers receiving homologous and heterologous COVID‐19 vaccination regimens
Wanitchaya Kittikraisak, Taweewun Hunsawong, Somsak Punjasamanvong, et al.
Influenza and Other Respiratory Viruses (2022) Vol. 16, Iss. 4, pp. 662-672
Open Access | Times Cited: 10
Why are children less affected than adults by severe acute respiratory syndrome coronavirus 2 infection?
Chang Kyung Kang, Hyun Mu Shin, Wan Beom Park, et al.
Cellular and Molecular Immunology (2022) Vol. 19, Iss. 5, pp. 555-557
Open Access | Times Cited: 10
Long Lasting Cellular Immune Response Induced by mRNA Vaccination: Implication for Prevention Strategies
Laura Vitiello, Lucia Gatta, Sara Ilari, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 10
System for classifying antibody concentration against severe acute respiratory syndrome coronavirus 2 S1 spike antigen with automatic quick response generation for integration with health passports
Apostolos Apostolakis, Dimitris Barmpakos, Sophie Mavrikou, et al.
(2024), pp. 20-29
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top